
Jan 13 (Reuters) - Gene sequencing company Illumina on Tuesday introduced a dataset that maps genetic changes to help accelerate drug discovery through artificial intelligence.
The company said it was partnering with drugmakers AstraZeneca, Merck and Eli Lilly for its Billion Cell Atlas, which will train advanced AI models at scale and advance research into fundamental disease mechanisms that have previously been out of reach.
Drug developers are increasingly adopting AI for discovery and safety testing to get faster and cheaper results, in line with the U.S. Food and Drug Administration's push to reduce animal testing in the near future.
Drug development software maker Certara and biotechs such as Schrodinger and Recursion Pharmaceuticals are using the booming technology to predict how experimental drugs might be absorbed, distributed or trigger toxic side-effects.
"We believe the Cell Atlas is a key development that will enable us to significantly scale AI for drug discovery," said Illumina CEO Jacob Thaysen.
The Atlas will capture how 1 billion individual cells respond to genetic changes via CRISPR across more than 200 disease-relevant cell lines.
These cell lines have been selected for their relevance to diseases, many of which have been historically difficult to decode, including immune disorders and cancer as well as cardiometabolic, neurological and rare genetic diseases.
The Atlas will enable users to characterize drug and disease mechanisms of action, explore potential new indications and validate candidate targets from human genetics.
(Reporting by Christy Santhosh in Bengaluru; Editing by Shilpi Majumdar)
LATEST POSTS
- 1
Barn Stored Lotus Esprit Turbo Seen After 30 Years - 2
Vote in favor of your Number one Kind of Shades - 3
Journey Lines for Each Explorer: Track down Your Ideal Journey - 4
Idris Elba is the king of the stress-watch - 5
Artemis II updates: NASA's moon mission breaks Apollo record for farthest distance humans have traveled from Earth
Vote in favor of the Top Vegetable for Senior
4 Dazzling And Well known Island Objections In US
Freed whale gets stranded again off German coast
The architect of Iran’s military survival remains defiant
NAFFIC and Aware to Launch First China-Europe Digital Product Passport
Lower-cost space missions like NASA's ESCAPADE are starting to deliver exciting science – but at a price in risk and trade‑offs
Old video misrepresented as senior Sri Lankan ruling party member criticising president over fuel shortage
Lift Your Style: Famous Hairdos for Ladies
Flu concerns grow in US as UK sees more cases among kids













